Literature DB >> 27806030

A morbidity/mortality analysis of a tertiary level upper gastrointestinal/hepatopancreaticobiliary surgical unit.

Susrutha K Wickremesekera1, Ho Beom Sean Seo2, Mary Anne Trimber3, Simon Bann4, Katherine Tse5.   

Abstract

Internationally, regionalisation of major upper gastrointestinal/hepatopancreaticobiliary (UGI/HPB) surgery to a selected number of expert hospital centres has demonstrated that high hospital volume is associated with lower mortality and morbidity. The Wellington UGI/HPB unit compared to international institutions is a low volume unit, however within New Zealand we perform a high number of Upper GI/HPB cases. AIMS: The aim of this study was to evaluate the quality measures of morbidity and mortality of major upper gastrointestinal and hepatopancreatobiliary surgeries performed at the Wellington UGI/HPB unit.
METHODS: An analysis was conducted to evaluate the major UGI/HBP surgeries performed at Wellington over a six-year period. Patient demographics, and morbidity and mortality were stratified using the Clavien-Dindo classification of surgical complications.
RESULTS: Three hundred and twenty-nine major elective cases were performed at the Wellington UGI/HPB unit over the six-year period. Sixty-five percent of patients experienced no morbidity, 19% of patients experienced mild morbidity, which had little effect on recovery, 14% of patients experienced major morbidity and 0.6% (two cases) progressed to mortality. When major UGI/HPB resections were specifically analysed, there were a total of 184 patients with 42 major morbidity (22.8%) and two mortalities (1.1%).
CONCLUSION: Compared with international standards, the Wellington UGI/HPB unit is a low volume centre but has delivered an acceptable quality of care with a low major morbidity and mortality for this type of surgery.

Entities:  

Mesh:

Year:  2016        PMID: 27806030

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  1 in total

1.  Association between tooth loss and upper gastrointestinal cancer: A 30-year follow-up of the Linxian Dysplasia Nutrition Intervention Trial Cohort.

Authors:  Su Zhang; Pei Yu; Jian-Bing Wang; Jin-Hu Fan; You-Lin Qiao; Philip R Taylor
Journal:  Thorac Cancer       Date:  2019-03-18       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.